GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Policy Acquisition Expense

Yumanity Therapeutics (FRA:8IY) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.